• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Fed’s Bullard: U.S. businesses having no problems raising prices

October 4, 2021 by David Barret Leave a Comment

October 4, 2021

(Reuters) – U.S. businesses are having few problems raising prices on customers for the first time in years, St. Louis Federal Reserve Bank President James Bullard said on Monday, as he warned that inflation could remain elevated for some time to come amid fears higher expectations become entrenched.

Bullard’s business contacts in his Fed district and around the country “typically say ‘don’t worry my company’s going to be profitable because I am going to raise prices and we’ve had no difficulty raising prices in this environment,’” Bullard said during an event held by the International Economic Forum of the Americas.

Bullard is among the strongest advocates at the U.S. central bank for aggressive moves to combat higher-than-expected inflation and he sees two interest rate hikes needed in 2022. Interest rates remain near zero currently, where they have been since the onset of the COVID-19 pandemic in early 2020.

“I am concerned about the changing mentality, I would say, around prices in the economy and the relative freedom that businesses feel that they can just pass on increased costs easily to their customers. For years, that’s not been the case,” Bullard added.

(Reporting by Lindsay Dunsmuir; Editing by)

Source Link Fed’s Bullard: U.S. businesses having no problems raising prices

David Barret
David Barret

Related posts:

  1. Apple M1X MacBook Pro might drop as early as October
  2. Monte dei Paschi prepares to close 50 branches – letter to unions
  3. Billions blown as Macau casino investors fold amid gambling review
  4. Cyclone Shaheen approaches Oman, flights delayed

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • US Just Killed NASA’s Mars Sample Return Mission – So What Happens Now?
  • Art Sleuths May Have Recovered Traces Of Da Vinci’s DNA From One Of His Drawings
  • Countries With The Most Narcissists Identified By 45,000-Person Study, And The Results Might Surprise You
  • World’s Oldest Poison Arrows Were Used By Hunters 60,000 Years Ago
  • The Real Reason You Shouldn’t Eat (Most) Raw Cookie Dough
  • Antarctic Scientists Have Just Moved The South Pole – Literally
  • “What We Have Is A Very Good Candidate”: Has The Ancestor Of Homo Sapiens Finally Been Found In Africa?
  • Europe’s Missing Ceratopsian Dinosaurs Have Been Found And They’re Quite Diverse
  • Why Don’t Snorers Wake Themselves Up?
  • Endangered “Northern Native Cat” Captured On Camera For The First Time In 80 Years At Australian Sanctuary
  • Watch 25 Years Of A Supernova Expanding Into Space Squeezed Into This 40-Second NASA Video
  • “Diet Stacking” Trend Could Be Seriously Bad For Your Health
  • Meet The Psychedelic Earth Tiger, A Funky Addition To “10 Species To Watch” In 2026
  • The Weird Mystery Of The “Einstein Desert” In The Hunt For Rogue Planets
  • NASA Astronaut Charles Duke Left A Touching Photograph And Message On The Moon In 1972
  • How Multilingual Are You? This New Language Calculator Lets You Find Out In A Minute
  • Europa’s Seabed Might Be Too Quiet For Life: “The Energy Just Doesn’t Seem To Be There”
  • Amoebae: The Microscopic Health Threat Lurking In Our Water Supplies. Are We Taking Them Seriously?
  • The Last Dogs In Antarctica Were Kicked Out In April 1994 By An International Treaty
  • Interstellar Comet 3I/ATLAS Snapped By NASA’s Europa Mission: “We’re Still Scratching Our Heads About Some Of The Things We’re Seeing”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2026 · Medical Market Report. All Rights Reserved.

Go to mobile version